# A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation

> **NCT07253753** · PHASE1 · RECRUITING · sponsor: **Yellowbird Diagnostics Inc** · enrollment: 12 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NeuCaVis

## Key facts

- **NCT ID:** NCT07253753
- **Lead sponsor:** Yellowbird Diagnostics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-08
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-06-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07253753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07253753, "A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07253753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*